Bulgaria's govt allocates further 23.5 mln euro for COVID-19 medication

Bulgaria's govt allocates further 23.5 mln euro for COVID-19 medication

Bulgaria's government said on Friday that it allocated an additional 46 million levs ($27.8 million/23.5 million euro) for the purchase of remdesivir, a medicine used in the treatment of COVID-19.

The new financing brings the total government expenditure for the purchase of remdesivir to 90 million levs, which should be enough to procure some 100,000 doses, the government said in a statement.

The funds allocated to date should be enough to secure the country's needs until the end of September, the government noted.

Remdesivir is manufactured by US-based company Gilead Sciences and sells under the Veklury brand name. Veklury was the first medicine approved by the European Commission for treatment of COVID-19.

According to data published by the health ministry on Friday, there are 321,104 confirmed cases of COVID-19 in Bulgaria, of which 64,120 still active.

Previous Next
Test Caption
Test Description goes like this
Cookies Preferences
Choose Type of Cookies You Accept Using

These cookies are required for the website to run and cannot be switched off. Such cookie are only set in response to actions made by you such as language, currency, login session, privacy preferences. You can set your browser to block these cookies but our site may not work then.

These cookies allow us to measure visitors traffic and see traffic sources by collecting information in data sets. They also help us understand which products and actions are more popular than others.

These cookies are usually set by our marketing and advertising partners. They may be used by them to build a profile of your interest and later show you relevant ads. If you do not allow these cookies you will not experience targeted ads for your interests.